Ortho Regenerative Technologies (Ortho RTi) initiated a six-month pivotal animal study on Ortho-R biopolymer for rotator cuff repair. A pre-Investigational New Drug meeting is scheduled with FDA to formalize requirements for the filing of an application to commence human trials on Ortho-R.
Three-month results from the animal study are expected to confirm previous findings of superior healing over standard of care, and will be used to assess whether the repair could be accelerated or improved with a higher dose of Ortho-R.
Ortho RTi’s proprietary biopolymer is designed to increase healing rates of sports related injuries to tendons, meniscus, ligaments and cartilage. The company is assessing its potential for therapeutic uses outside of soft tissue repair, as well.
Ortho Regenerative Technologies (Ortho RTi) initiated a six-month pivotal animal study on Ortho-R biopolymer for rotator cuff repair. A pre-Investigational New Drug meeting is scheduled with FDA to formalize requirements for the filing of an application to commence human trials on Ortho-R.
Three-month results from the animal study are expected...
Ortho Regenerative Technologies (Ortho RTi) initiated a six-month pivotal animal study on Ortho-R biopolymer for rotator cuff repair. A pre-Investigational New Drug meeting is scheduled with FDA to formalize requirements for the filing of an application to commence human trials on Ortho-R.
Three-month results from the animal study are expected to confirm previous findings of superior healing over standard of care, and will be used to assess whether the repair could be accelerated or improved with a higher dose of Ortho-R.
Ortho RTi’s proprietary biopolymer is designed to increase healing rates of sports related injuries to tendons, meniscus, ligaments and cartilage. The company is assessing its potential for therapeutic uses outside of soft tissue repair, as well.
Source: Ortho Regenerative Technologies Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.